Tagged: Myriad

Appeals court concludes that Myriad can patent BRCA genes - Code for life

Grant Jacobs Jul 30, 2011

Friday saw the US Court of Appeals for the Federal Circuit (which we’re told by the New York Times told specialises in patent cases) rule that Myriad can patent the isolated BRCA1 and BRCA2 genes, mutations in which are diagnostic for (some) cases of breast and ovarian cancers. The three judges didn’t rule unanimously, with … Read More